|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 113.79 CAD | -0.54% |
|
+9.90% | +34.31% |
| 03-13 | NUTRIEN : RBC maintains a Buy rating | ZD |
| 03-13 | Wells Fargo Upgrades Nutrien to Overweight From Equalweight, Adjusts Price Target to CA$136.26 From CA$105.46 | MT |
Company Valuation: Nutrien Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 42,885 | 37,993 | 27,955 | 22,079 | 29,865 | 39,846 | - | - |
| Change | - | -11.41% | -26.42% | -21.02% | 35.26% | 33.42% | - | - |
| Enterprise Value (EV) 1 | 53,232 | 49,020 | 39,580 | 34,033 | 41,183 | 49,284 | 49,198 | 48,324 |
| Change | - | -7.91% | -19.26% | -14.01% | 21.01% | 19.67% | -0.17% | -1.78% |
| P/E ratio | 13.6x | 5.15x | 22.3x | 32.9x | 13.3x | 14.8x | 16.6x | 17.7x |
| PBR | 1.77x | 1.43x | 1.12x | 0.9x | 1.19x | 1.52x | 1.49x | 1.41x |
| PEG | - | 0x | -0.3x | -0.7x | 0x | 0.7x | -1.6x | -2.74x |
| Capitalization / Revenue | 1.6x | 1.03x | 1x | 0.88x | 1.15x | 1.47x | 1.49x | 1.47x |
| EV / Revenue | 1.98x | 1.32x | 1.41x | 1.36x | 1.59x | 1.82x | 1.83x | 1.78x |
| EV / EBITDA | 7.47x | 4.03x | 6.53x | 6.36x | 6.81x | 7.73x | 8.09x | 8.07x |
| EV / EBIT | 11.1x | 4.54x | 14.4x | 18.3x | 11x | 11.8x | 13x | 13.8x |
| EV / FCF | 25.3x | 8.64x | 16.5x | 24.6x | 20.6x | 18.8x | 20.2x | 23.2x |
| FCF Yield | 3.95% | 11.6% | 6.05% | 4.06% | 4.86% | 5.33% | 4.95% | 4.31% |
| Dividend per Share 2 | 1.84 | 1.92 | 2.12 | 2.16 | 2.18 | 2.207 | 2.241 | 2.252 |
| Rate of return | 2.45% | 2.63% | 3.75% | 4.83% | 3.53% | 2.67% | 2.71% | 2.72% |
| EPS 2 | 5.52 | 14.18 | 2.53 | 1.36 | 4.66 | 5.591 | 4.995 | 4.672 |
| Distribution rate | 33.3% | 13.5% | 83.8% | 159% | 46.8% | 39.5% | 44.9% | 48.2% |
| Net sales 1 | 26,861 | 37,012 | 28,082 | 25,016 | 25,949 | 27,127 | 26,822 | 27,175 |
| EBITDA 1 | 7,126 | 12,170 | 6,058 | 5,355 | 6,046 | 6,378 | 6,081 | 5,988 |
| EBIT 1 | 4,781 | 10,809 | 2,745 | 1,856 | 3,736 | 4,181 | 3,789 | 3,492 |
| Net income 1 | 3,153 | 7,660 | 1,258 | 674 | 2,267 | 2,728 | 2,366 | 2,334 |
| Net Debt 1 | 10,347 | 11,027 | 11,625 | 11,954 | 11,318 | 9,438 | 9,352 | 8,478 |
| Reference price 2 | 75.13 | 73.04 | 56.53 | 44.70 | 61.79 | 82.82 | 82.82 | 82.82 |
| Nbr of stocks (in thousands) | 570,786 | 520,184 | 494,547 | 493,910 | 483,341 | 481,141 | - | - |
| Announcement Date | 16/02/22 | 15/02/23 | 21/02/24 | 19/02/25 | 18/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- NTR Stock
- Valuation Nutrien Ltd.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















